BAFNAPH.NS

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Pharmaceuticals

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
BAFNAPH.NSBafna Pharmaceuticals Limited	$308.25	+0.31%	$7.3B	—
BROOKS.BOBrooks Laboratories Limited	$61.77	-3.53%	$1.8B	—
BROOKS.NSBrooks Laboratories Limited	$61.01	-3.30%	$1.8B	—
MEDICO.BOMedico Remedies Limited	$35.38	-1.37%	$2.9B	—
MEDICO.NSMedico Remedies Limited	$35.48	-0.56%	$2.9B	—
NECLIFE.BONectar Lifesciences Limited	$11.03	-3.08%	$2.1B	—
NECLIFE.NSNectar Lifesciences Limited	$10.97	-3.77%	$2.1B	—

Source: Financial Modeling Prep · peers by sector/industry

Bafna Pharmaceuticals Limited

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

www.bafnapharma.com

Employees: 339
IPO / List date: Dec 28, 2005
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds BAFNAPH.NS.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in BAFNAPH.NS as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded BAFNAPH.NS yet.